On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
Ural State Medical University, Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of the Russian Federation (hereinafter referred to as the University, USMU) is the leading scientific, educational and methodological center in the Ural Federal District, which has been successfully training highly qualified medical personnel for 90 years, which has formed health care human resources of Sverdlovsk region and the Urals region and made a significant contribution to personnel training in the field of medical science and practice of the country.
“Vector of the USMU mission is aimed at strengthening the University's driving role for the innovative development of the healthcare system to attract talented young persons; integration of resources of educational, scientific institutions, industrial partners in the field of biomedicine, pharmacy and medical engineering; generation of high-tech innovative environment; creation of key elements for knowledge base of the platform “Medicine of the Future”; active introduction of integrated health-saving technologies; sustainable development of socio-cultural environment and human capital.
University target model transformation involves transition from a model of an educational institution to the model of a reference multidisciplinary (educational, scientific, innovative, practice-oriented) institution, which is a key element of networking cooperation between leading educational and scientific institutions, health care institutions, technological clusters and high-tech innovative enterprises of Sverdlovsk Region, Ural Federal District and neighboring states.
USMU is a coordinator of the Urals Scientific and Educational Medical Cluster, the base university of the Urals Scientific and Educational Consortium of Biomedicine, Pharmacy and Medical Engineering, created jointly by institutes of the Ural Branch of the Russian Academy of Sciences.
Active cooperation of the University with industrial partners – enterprises of the state corporations Rosatom, Roscosmos, Rostech, manufacturers of medical equipment, pharmaceuticals, creates conditions for formation of a high-tech complex of production and infrastructure facilities for technologies development and transfer, production of modern medicines, equipment and medical devices in the Urals.
USMU projects are implemented in the Ural Interregional Scientific and Educational World-Class Center «Advanced Production Technologies and Materials» in the field of «Bioequivalent Materials for Dentistry, Surgery, Traumatology».
Commitment to longstanding traditions and susceptibility to innovations in educational, research and clinical activities, enabled the University to achieve international recognition.
Since 2012, USMU has been included in the Top 100 best universities of Russia, Top 20 universities of «Medicine and Health Care», international rankings «Three missions of universities» and Times Higher Education.
According to the results of competitive selection in 2021, the University entered the strategic academic leadership program “Priority 2030” of the Ministry of Higher Education and Science of the Russian Federation.
Address: 3, Repina St., Ekaterinburg, 620028
Tel.: (343) 214-86-52
Email: usma@usma.ru